Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2007

Open Access 01.04.2007 | Tribute

Prof. Ilja Braveny 1940–2007

verfasst von: Jan Verhoef

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2007

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
https://static-content.springer.com/image/art%3A10.1007%2Fs10096-007-0284-6/MediaObjects/10096_2007_284_Figa_HTML.jpg
On 2 February 2007, Ilja Braveny, Professor of Clinical Microbiology and Editor-in-Chief of the European Journal of Clinical Microbiology & Infectious Diseases (EJCMID), died unexpectedly. His death is a great loss, not only for his family and friends, but for all who work in the field of microbiology.
Personally, I have known Ilja since 1981. We met briefly during the First International Symposium on Infections in the Immunocompromised Host in Veldhoven in 1981. After one fortuitous telephone conversation in the autumn of that same year, we became much better acquainted. In that phone call, Ilja told me he had launched a medical journal, the European Journal of Clinical Microbiology. This was at a time when no comparable forum outside of the USA existed, and Ilja wanted to address that deficit. He firmly believed in the competency of European medical microbiologists and felt they should have their own voice in a journal and in microbiology-related meetings. Further to founding the journal, he asked me to join a group of European microbiologists to discuss the possibility of organizing a European microbiological society. He had ambition. He wanted to put European microbiology on the map.
Ilja’s vision was to start the European Society of Clinical Microbiology (ESCM), an organization that could host microbiologists from around the world at meetings similar to the well-attended International Conference on Antimicrobial Agents and Chemotherapy and those organized by the American Society for Microbiology. With this goal in mind, he invited a group of well-respected European microbiologists (including Bjorn Hoffstedt, Jacques Acar, David Williams, Otto Zak, Arturo Visconti, and Evilio Perea, among others) to come together in the Bavarian Alps. There, Ilja’s ideas for holding European meetings and forming a European society were discussed. His vision was clear: We European microbiologists should organize ourselves in a society. And that is what we did.
There, in one old Bavarian tavern, the ESCM (Ilja’s brainchild) was born. He was such a good host and organizer that Munich, where he worked, remained the seat of the ESCM and the place where we met regularly in the 1980s. It was also in Munich that he later suggested the society should additionally serve as a platform for infectious diseases specialists. Thus, it became the European Society for Clinical Microbiology and Infectious Diseases (ESCMID).
Meanwhile, Ilja devoted many hours to developing his journal, now known as the European Journal of Clinical Microbiology & Infectious Diseases (EJCMID). This important European forum has become firmly established as a valuable vehicle for science in the field of microbiology. Ilja Braveny was an excellent editor, with sound judgment and a fair disposition. He was also a highly competent scientist. As such, he recognized the value of meeting with other scientists to collaborate and to exchange ideas. As a further testament to his belief in international collaboration, he sent many of his assistants and junior scientists abroad for training.
Ilja Braveny was a personal friend, a gracious host, and an amiable and warm-hearted person. He was a pioneer with exceptional foresight and extraordinary ideas matched by the necessary drive to implement them. He was also a good sportsman, a terrific skier. I have fond memories of our skiing trips to Austria and Italy, where we discussed the future of European microbiology. His passing has occurred much too early. He is dearly missed and will always be remembered and admired for his significant contributions to fostering science in microbiology.
May he rest in peace.
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://​creativecommons.​org/​licenses/​by-nc/​2.​0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Metadaten
Titel
Prof. Ilja Braveny 1940–2007
verfasst von
Jan Verhoef
Publikationsdatum
01.04.2007
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2007
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0284-6

Weitere Artikel der Ausgabe 4/2007

European Journal of Clinical Microbiology & Infectious Diseases 4/2007 Zur Ausgabe

Announcements

Announcements

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.